Proactive Investors - Finance
13 Jul 2026, 11:40 UTC · 1h ago
Orthocell delivers record FY2026 revenue as US Remplir rollout accelerates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Proactive Investors - Finance
13 Jul 2026, 11:40 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Orthocell achieved record FY2026 revenue of A$13.2 million, a 44% increase year-over-year. — Strong top-line growth and record revenue typically signal successful product market fit and commercial scalability.
+0.60The company has obtained approval for its Remplir device across the US Department of Defence and Veterans Affairs healthcare networks. — Access to these networks provides a massive, consolidated channel for growth, opening potential access to 221 medical centers.
+0.50Orthocell reports A$44.1 million in available funds and states it does not require additional funding for its current commercialization and expansion plans. — Strong liquidity reduces the immediate risk of equity dilution for shareholders while funding US growth.
+0.40Continue reading
6 related stories
Top 3 movers · tap to explore
US surgeon adoption grew by 55% and hospital purchases increased by 27% during the June quarter. — These leading indicators of adoption suggest accelerating momentum in the critical US market.
+0.30Which stocks this story touches
The company reported record quarterly and full-year revenue with strong growth in US and Australian markets.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Proactive Investors
1h ago
